🇺🇸 FDA
Pipeline program

CB-010

CB10LUPA

Phase 1 small_molecule terminated

Quick answer

CB-010 for Systemic Lupus Erythematosus is a Phase 1 program (small_molecule) at Caribou Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Caribou Biosciences
Indication
Systemic Lupus Erythematosus
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials